Literature DB >> 9461489

Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway.

S Thiel1, I Behrmann, E Dittrich, L Muys, J Tavernier, J Wijdenes, P C Heinrich, L Graeve.   

Abstract

Signalling receptors often undergo receptor-mediated endocytosis. In many cases this internalization is stimulated by ligand binding and activation of intrinsic receptor tyrosine kinases, resulting in a receptor down-regulation. We have analysed whether internalization of the interleukin 6 signal transducer gp130 is dependent on the activation of receptor-associated Jak kinases. By using a chimaeric receptor system we found that receptor mutants that lack box1 and therefore are not capable of activating Jak and signal transducer and activator of transcription (STAT) proteins are still endocytosed efficiently. A chimaeric receptor with the recently identified dileucine internalization motif being replaced by two alanine residues was not efficiently internalized but still capable of recruiting STATs. Furthermore an antagonistic antibody that inhibits the signalling of all interleukin-6-type cytokines via gp130 was internalized as efficiently as an agonistic one that activates the Jak/STAT pathway. Our findings suggest that the endocytosis of gp130 is signal-independent.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461489      PMCID: PMC1219106          DOI: 10.1042/bj3300047

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  A single STAT recruitment module in a chimeric cytokine receptor complex is sufficient for STAT activation.

Authors:  I Behrmann; C Janzen; C Gerhartz; H Schmitz-Van de Leur; H Hermanns; B Heesel; L Graeve; F Horn; J Tavernier; P C Heinrich
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

2.  Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies.

Authors:  J R Glenney; W S Chen; C S Lazar; G M Walton; L M Zokas; M G Rosenfeld; G N Gill
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

3.  The protein-tyrosine kinase activity of the insulin receptor is necessary for insulin-mediated receptor down-regulation.

Authors:  D S Russell; R Gherzi; E L Johnson; C K Chou; O M Rosen
Journal:  J Biol Chem       Date:  1987-08-25       Impact factor: 5.157

4.  Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing.

Authors:  A M Honegger; T J Dull; S Felder; E Van Obberghen; F Bellot; D Szapary; A Schmidt; A Ullrich; J Schlessinger
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

5.  A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.

Authors:  D A McClain; H Maegawa; J Lee; T J Dull; A Ulrich; J M Olefsky
Journal:  J Biol Chem       Date:  1987-10-25       Impact factor: 5.157

6.  The signalling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements.

Authors:  J Yuan; U M Wegenka; C Lütticken; J Buschmann; T Decker; C Schindler; P C Heinrich; F Horn
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

7.  Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130.

Authors:  C Lütticken; U M Wegenka; J Yuan; J Buschmann; C Schindler; A Ziemiecki; A G Harpur; A F Wilks; K Yasukawa; T Taga
Journal:  Science       Date:  1994-01-07       Impact factor: 47.728

8.  Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.

Authors:  J Wijdenes; P C Heinrich; G Müller-Newen; C Roche; Z J Gu; C Clément; B Klein
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

9.  Effect of receptor kinase inactivation on the rate of internalization and degradation of PDGF and the PDGF beta-receptor.

Authors:  A Sorkin; B Westermark; C H Heldin; L Claesson-Welsh
Journal:  J Cell Biol       Date:  1991-02       Impact factor: 10.539

10.  Kinetics of binding, endocytosis, and recycling of EGF receptor mutants.

Authors:  S Felder; J LaVin; A Ullrich; J Schlessinger
Journal:  J Cell Biol       Date:  1992-04       Impact factor: 10.539

View more
  14 in total

1.  A single amino acid substitution (Trp(666)-->Ala) in the interbox1/2 region of the interleukin-6 signal transducer gp130 abrogates binding of JAK1, and dominantly impairs signal transduction.

Authors:  C Haan; H M Hermanns; P C Heinrich; I Behrmann
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

2.  Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation.

Authors:  Claude Haan; Peter C Heinrich; Iris Behrmann
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

3.  IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling.

Authors:  Daniel Traum; Patricia Timothee; Jonathan Silver; Stefan Rose-John; Matthias Ernst; David F LaRosa
Journal:  J Leukoc Biol       Date:  2011-12-02       Impact factor: 4.962

Review 4.  Eliminative signaling by Janus kinases: role in the downregulation of associated receptors.

Authors:  Christopher J Carbone; Serge Y Fuchs
Journal:  J Cell Biochem       Date:  2014-01       Impact factor: 4.429

5.  Signaling through a novel domain of gp130 mediates cell proliferation and activation of Hck and Erk kinases.

Authors:  M Schaeffer; M Schneiderbauer; S Weidler; R Tavares; M Warmuth; G de Vos; M Hallek
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

6.  Identification of a Leu-lle internalization motif within the cytoplasmic domain of the leukaemia inhibitory factor receptor.

Authors:  S Thiel; I Behrmann; A Timmermann; H Dahmen; G Müller-Newen; F Schaper; J Tavernier; V Pitard; P C Heinrich; L Graeve
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

Review 7.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

Review 8.  Proinflammatory stem cell signaling in cardiac ischemia.

Authors:  Jeremy L Herrmann; Troy A Markel; Aaron M Abarbanell; Brent R Weil; Meijing Wang; Yue Wang; Jiangning Tan; Daniel R Meldrum
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

9.  The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.

Authors:  Josiane Ragimbeau; Elisabetta Dondi; Andrés Alcover; Pierre Eid; Gilles Uzé; Sandra Pellegrini
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

10.  Alcohol consumption impairs hepatic protein trafficking: mechanisms and consequences.

Authors:  Blythe D Shepard; David J Fernandez; Pamela L Tuma
Journal:  Genes Nutr       Date:  2009-11-05       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.